This Week in Psychedelics - 3.4.22

Cannabis

• Maryland House Advances Cannabis Legalization Bills (High Times)

• D.C. Lawmakers Approve Ban On Pre-Employment Marijuana Testing For Most Workers (Marijuana Moment)

• Where does Biden’s Supreme Court nominee stand on marijuana legalization? Here’s what we found (Leafly)

• Medicinal Cannabis Flower Sales Begin In Minnesota (High Times)

• Virginia House Committee Kills Bill To Begin Marijuana Sales This Year (Marijuana Moment)

• Rhode Island Lawmakers Introduce Cannabis Legalization Bill (High Times)

• NCAA Moves To Lower Marijuana Penalties For Student Athletes And Increase THC Threshold In Drug Tests (Marijuana Moment)

• Nebraska Medical Cannabis Bill Fizzles in Committee (High Times)

• Get ready for the Northeast to become cannabis country (Politico)

• France Moves to Begin Cultivating Medical Cannabis (High Times)

• Virginia lawmakers cracking down on cannabis compound Delta-8 due to safety concerns (WAVY)

• South Dakota House Rejects Marijuana Legalization Bill That Was Temporarily Revived In ‘Smoke Out’ Vote (Marijuana Moment)

• Ecuador Kicks Off Medical Cannabis Production (High Times)

• Washington state to require pesticide testing for adult-use cannabis products (Marijuana Business Daily)

• Ohio Lawmakers Advance Bill To Allow Medical Cannabis for Autism (High Times)

• Confusion over CBD for Children (Drug WarRant)

• Pennsylvania Senate Committee Holds Second Marijuana Legalization Hearing As Reform Bill Is Drafted (Marijuana Moment)

• Georgia Lawmakers Consider Bill to Expand Medical Pot Program (High Times)

LSD

• Landmark trial compares LSD and psilocybin trips, finds few differences (New Atlas)

• Mystical experiences might bridge the gap between LSD-induced “madness” and healing (PsyPost)

Magic Mushrooms

• Colorado may be the next state to decriminalize ‘magic’ mushrooms (The Durango Herald)

• Terminal cancer patient denied magic mushrooms after Health Canada rule change (CBC)

• Psilocybin Leaps Ahead of Other Psychedelics in Trials and Studies (Lucid News)

• The Plan to Reschedule Psilocybin at the UN (TalkingDrugs)

• 'We need emergency access': 82 Canadian professionals request psilocybin for therapy training (Vancouver Sun)

• Oregonians more interested in taking psilocybin for well-being than depression or anxiety (OPB)

• How Will Oregon Teach and Train Psilocybin Healers? (Filter)

• Magic mushrooms, psilocybin and microdosing: Growing trend draws e-vendors, scientists (CBC)

MDMA

• Can MDMA Help Heal Grief? (Lucid News)

5-MeO-DMT

• Could 5-MeO-DMT Allow For More Affordable Psychedelic-Assisted Therapy? Beckley Psytech Thinks So (Forbes)

Iboga

• MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program (PR Newswire)

Novel Psychoactive Substances

• PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma (Psilocybin Alpha)

Synthetic Cannabinoids

• CBP Officers and Scientists Identify Two New Synthetic Cannabinoid Analogues (Homeland Security Today)

Ketamine

• Dr. Bronner’s to Provide Psychedelic-Therapy as Employee Healthcare Benefit (Dr. Bronner's)

• Ketamine Could Treat Alcohol Use Disorder, Study Shows (Lucid News)

• Dying to Stay Alive: A Ketamine Disaster (Mad in America)

• Yale researchers study ketamine as a potential treatment for depression in patients with Parkinson’s disease (Yale Daily News)

• Adding Lithium Might Enable Ketamine's Antidepressant Activity in Ketamine-Resistant Patients, Study Suggests (Brain and Behavior Research Foundation)

Miscellaneous

• It’s Time to Start Studying the Downside of Psychedelics (VICE)

• Utah Psychedelics And Mental Health Bill Heads To Governor’s Desk After Senate Approval (Marijuana Moment)

• In Oregon, Psychedelics Regulators Confront Conflicts of Interest (VICE)

• More People Are Microdosing for Mental Health. But Does It Work? (The New York Times)

• The Need for an International Psychedelic Religious Survey (Psychedelics Today)

• Psychedelic Therapeutics Market May Receive Federal Approval Before Marijuana Does (MarketWatch)

• Staring into the Abyss: Examining Venezuela’s Drug Policies (TalkingDrugs)

• Global Survey: Some Microdosing Individuals Have Altered Psychiatric Drug Dosage (Psychiatry Advisor)

• How Psychedelics Will Impact Mainstream Product Development (Yahoo!)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.29.21

Cannabis

• With export restrictions eased, Colombia's medical cannabis business is poised for liftoff (CNN)

• Federal Survey Identifies Marked Decline in Youth Marijuana Use (NORML)

• Why did Texas ban Delta-8? (Popular Science)

• Cannabis products may help treat symptoms of depression, improve sleep, and increase quality of life, study suggests (PsyPost)

• California Destroys 1M Plants in Marijuana Eradication Campaign (High Times)

• State Attorneys General Warn About Marijuana-Infused Candy And Snacks Ahead Of Halloween (Marijuana Moment)

• The Myth of Cannabis-Infused Halloween Candy—Debunked (High Times)

• Cannabis is one industry that's actually coming out of Covid even stronger (CNN)

• South Dakota Lawmakers Approve Marijuana Legalization Bill As Activists Pursue 2022 Ballot Initiative (Marijuana Moment)

• New York: Officials Moving to Clear Over 400,000 Past Marijuana Convictions (NORML)

• Montana Supreme Court Unanimously Overturns a Pot Conviction, Saying Cops Stopped the Defendant for No Good Reason (Reason)

• Analysis: ‘Government-Grade’ Marijuana More Closely Resembles Hemp, Has Little in Common with Commercially Available Cannabis (NORML)

• Florida judge rules online marijuana ordering sites may resume business (Marijuana Business Daily)

• Louisiana plans to regulate, not ban, delta-8 THC (Marijuana Business Daily)

• Former Arkansas Lawmaker Launches Campaign To Put Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

• Maryland: Most Residents Want to Legalize Marijuana for Adult Use (NORML)

LSD

• Ex-Denver Cop Who Broke Teen's Face for Dancing on LSD to Cost City $1.2 Million (Westword)

Magic Mushrooms

• Study Finds Psilocybin Improves MDD in Patients With Cancer (Psychiatric Times)

• Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property (STAT)

• Italian Activists Turn In More Than Half A Million Signatures For Marijuana And Psilocybin Referendum (Marijuana Moment)

• Dr. Bronner’s Funds Psilocybin Legalization Effort in Connecticut (High Times)

• More Evidence of the Chemical Compound Variability in Magic Mushrooms (Psychedelic Science Review)

• MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias (Psilocybin Alpha)

• Nova Mentis Earns Psilocybin Orphan Drug Designation in Europe for Fragile X Syndrome (PR Newswire)

MDMA

• No One Is Wasting Their Ecstasy on Your Kids' Halloween Candy (Reason)

• MindMed Announces R(-)-MDMA Program to target Social Anxiety Associated with Autism Spectrum Disorder (Psilocybin Alpha)

Ayahuasca

• Des Moines church fights IRS over ‘religious’ use of hallucinogenic drug (Iowa Capital Dispatch)

5-MeO-DMT

• Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial Assessing Safety and Tolerability of Intranasal 5-MeO-DMT (Psilocybin Alpha)

Novel Psychoactive Substances

• Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin (Psilocybin Alpha)

• Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer’s Disease (Psilocybin Alpha)

• Awakn Life Sciences Identifies New Chemical Series Via Its Drug Discovery Program (Awakn Life Sciences)

• Marvel Biosciences Announces New Program to Develop Novel Orally Dosed Non-Hallucinogenic Neuroplastic Promoting Compounds (Yahoo! Finance)

Synthetic Cannabinoids

• The Dangers of 'Spice' and Other Synthetic Cannabinoids (Discover Magazine)

Ketamine

• European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive Disorders (Psilocybin Alpha)

• Cocaine, ketamine use on the rise: survey (PerthNow)

• Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow Technology (Psilocybin Alpha)

• MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE’s Digital Therapeutics Platform (Psilocybin Alpha)

Miscellaneous

• Canadian entrepreneur gifts $5 million to help create psychedelic research centre for mental health (CTV News)

• Where the Psychedelic Revolution Is Headed, According to the Guy Who (Arguably) Started It (GQ)

• Psychedelics Group Issues First Round Of Grants For Community-Based Entheogenic Education In DC (Marijuana Moment)

• Addressing Abuse in Psychedelic Spaces (Psychedelics Today)

• North America Continues Leading The Way In Psychedelic Wellness (PR Newswire)

• Psychedelic Patents Should Be Limited, Harvard Law Experts Say (Psychedelic Spotlight)

• Could Psychedelics Cure Our Post-Pandemic Depression? (Truffle Report)

• How Gender Affects the Way We Use Drugs (TalkingDrugs)

• DC Voters Strongly Support Drug Decriminalization, Poll Finds As Activists Launch Campaign (Marijuana Moment)

• MAPS Canada’s Data Breach Foreshadows Corporadelic Future (Psymposia)

• Wavepaths: The Neuroscientist-Founded Company Producing Music For—And As—Psychedelic Therapy (Forbes)

• Novamind Brings Contract Research To Psychedelic Medicine (Lucid News)

• Psychedelic Research Beyond Depression & Trauma (Truffle Report)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Month in Psychedelics - March 2021

March was yet another busy month in the world of psychedelics. There was plenty of news involving drug policy, scientific research, the emerging psychedelic industry, and more. So if you’re looking to learn more about what happened this month in psychedelics then you’re in the right place!

Here is a slimmed-down video recap version that is available for those who prefer an easier-to-digest option:

There’s a lot to get through this month, so without further ado, let’s jump into the news:

Drug Policy

New Laws

Kicking things off, two new decriminalization laws took effect in the United States this month.

Washington D.C. decriminalized natural psychedelics like ayahuasca and psilocybin mushrooms and the capital city isn’t stopping there. The Plant Medicine Coalition is pushing the District Council to enact more legislation that would provide worker and child protections related to the use of plant- and fungi-based substances, among other initiatives that the group is working on.

Baltimore did something a bit surprising by decriminalizing all drugs as well as prostitution and several other low-level offenses. This move is part of an overall experiment known as The Covid Criminal Justice Policies, and it’s a unique approach to crime that was developed with public health authorities and inspired by the global pandemic. Instead of prosecuting people arrested for minor crimes, the program looks at them as public health issues and partners with organizations in the community to help find solutions rather than punish offenders.

Wins

In last month’s recap I reported that both Virginia’s House and Senate voted to legalize cannabis, but what I didn’t realize at the time was that each one of them approved a separate bill. Now Virginia’s House and Senate have both approved the same bill, which is currently on Governor Ralph Northam’s desk awaiting a signature that would make cannabis legal in the state by 2024.

However, Northam has thrown around the idea of moving up the legalization date to this July 1st and the leaders of Virginia’s House have expressed their support for this idea, so it’s possible that weed will be legal in the Old Dominion this summer.

Cannabis reform bills made advances in several other states as well: Hawaii, Wyoming, New York, Connecticut, and Illinois. And south of the border, Mexico’s lawmakers advanced a bill to legalize recreational cannabis, bringing the country one step closer to becoming one of the world’s largest marijuana markets.

Losses

Not all drug policy reform efforts were successful, however. Mississippi’s House killed the state’s medical marijuana bill, although the Senate hasn’t given up yet and is attempting a last-ditch effort to revive the bill. And Maryland’s cannabis legalization effort officially threw in the towel, so residents of the Old Line State will need to wait for either a future federal- or state-level initiative to enjoy legal marijuana from the comfort of their own homes.

New Bills and Initiatives

And there’s plenty drug policy news on the horizon as well—a New York lawmaker filed a bill to decriminalize psilocybin mushrooms in the state, lawmakers in Vermont and Rhode Island proposed decriminalizing all drugs, and activists in Michigan launched a campaign to decriminalize natural psychedelics.

Psychedelic Industry

Following on the heels of last month’s news that COMPASS Pathways is attempting to patent basic, preexisting psychedelic therapy techniques like using soft furniture and holding hands, the debate about patenting various aspects involving psychedelics continued to rage on this month.

A few well-known investors and players in the psychedelic industry had something to say about patents, including Rick Doblin, Tim Ferriss, Christian Angermayer, and David Bronner. At the heart of the matter is the fact that COMPASS Pathways has submitted patent applications for so many things involving psilocybin that Psymposia put together an astounding article detailing them that’s definitely worth checking out.

This is an important area to keep an eye on because it will impact all sorts of things, including who will be able to legally access and use psychedelics and which companies will be able to turn a profit in the emerging psychedelic industry.

Psychedelic Research

Researchers at Imperial College London published results from a groundbreaking placebo-controlled LSD microdosing trial. The study found that while participants who microdosed with active LSD ended up experiencing beneficial psychological effects, the placebos also engendered the same result. In fact, there was no statistical significance between an LSD microdose and a placebo pill.

This could mean that the benefits of microdosing come down to the placebo effect rather than an actual effect, but this study is by no means a definitive confirmation of that hypothesis. The study’s limitations include a relatively small sample size of 191 volunteers and a unique (and potentially flawed) self-blinding protocol.

More microdosing research will need to be conducted before we have a solid idea about its efficacy, but until then I’m sure microdosers will keep microdosing and getting benefits out of their practice regardless of whether those benefits come down to the psychedelic substance itself or the placebo effect.

In another study, researchers analyzed data from more than 171,000 adults who responded to the National Survey on Drug Use and Health between 2015 and 2018 and found that the use of psychedelics is associated with better physical health.

Roughly 14% of the sample reported using a classical psychedelic like LSD, mescaline, psilocybin, or DMT at least one time, and after controlling for a number of variables the results showed that those who reported ever using psychedelics tended to have better health than people who had never used a psychedelic before. Psychedelic users also had significantly lower odds of being overweight or obese.

It’s important with a study like this to remember that correlation doesn’t equal causation, but it’s interesting to know that a study with such a large sample size and variable controls found physical health to be significantly better among psychedelic users than the psychedelically-naïve.

Miscellaneous

Although many people in the psychedelic and wider drug-using communities were hopeful about President Joe Biden and Vice President Kamala Harris’ approach to drug policy, so far things haven’t exactly gotten off on the right foot. In addition to the fact that the drug war is still going strong, several White House staffers were asked to resign, were suspended, or are being required to work remotely after revealing past cannabis use during their background checks, even if that use occurred in states where marijuana has been legalized. This isn’t too surprising though, considering that cannabis is still illegal at the federal level, which can make it challenging for government employees to get federal security clearance.

However, what makes this extra frustrating is that several staffers had been previously told by transition officials that past cannabis use would be overlooked, only to be told later that they would need to resign. This flip-flopping is par for the course when it comes to politicians and politics in general, but it’s still aggravating to see Biden’s administration pull a bait-and-switch here.

Hopefully in the future they’ll be able to relax a bit and not exclude people on the basis of prior drug use. I know a natural remedy that might help them chill out but something tells me they won’t be interested…

Last up this month is a story about why PCP users almost exclusively live in America. The linked VICE article explores the curious reasons behind why the drug never went global like crack cocaine or LSD.

That’s all for this month’s update. Remember to always test and weigh your drugs and until next time—keep thinking wilder.

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

This Week in Psychedelics - 3.19.21

Cannabis

• White House staffers asked to resign or work remotely after revealing past marijuana use (CNN)

• Wyoming Lawmakers Approve Marijuana Legalization Bill Sponsored By Top GOP Leaders (Marijuana Moment)

• Wisconsin GOP Lawmakers File Bill To Decriminalize Marijuana, While Governor Pushes Full Legalization (Marijuana Moment)

• Nebraska Gov. Ricketts warns: 'If you legalize marijuana, you're going to kill your kids' (USA Today)

• People of Color Made Up 94% of All Pot Arrests in New York in 2020, NYPD Data Reports (MERRY JANE)

• Marijuana Banking Bill Reintroduced In Congress With Broad Bipartisan Support From More Than 100 Lawmakers (Marijuana Moment)

• Big Alcohol and Big Tobacco Coalition Emerges to Shape Legalization in Their Favor (NORML)

• Delaware Lawmakers File Marijuana Legalization Bill Despite Governor’s Ongoing ‘Concerns’ (Marijuana Moment)

• New Mexico Marijuana Legalization Bill Heads To Senate Floor Following Contentious Committee Hearing (Marijuana Moment)

• Colorado Is Trying to Implement 15% THC Cap on High-Potency Cannabis Concentrates (MERRY JANE)

• North Dakota Marijuana Legalization Bill Receives First Senate Committee Hearing Following House Passage (Marijuana Moment)

• Congress and USPS Inadvertently Restrict Consumer Access To Vaporizer Cartridges, Batteries, Etc (NORML)

• New PTSD study finds cannabis safe, but not as effective as assumed (Leafly)

• Pennsylvania: Police Arrested 20,200 Adults for Marijuana Possession During Pandemic (NORML)

• New Evidence Shows CBD Can Help Fight Alzheimer's Disease (MERRY JANE)

• Medical cannabis can reduce essential tremor: turns on overlooked cells in central nervous system (EurekAlert!)

• Cultivating a Single 8th of Weed Creates 41-Pound Carbon Footprint, Study Finds (MERRY JANE)

LSD

• The true story of Michel Foucault's LSD trip that changed history (Salon)

Magic Mushrooms

• COMPASS Pathways Is Trying to Patent Psilocybin for More Mental Health Conditions Than You Can Name (Psymposia)

• Experts chosen to create Oregon’s new system of psilocybin-assisted therapy (OPB)

• Can Magic Mushrooms Heal Us? (The New York Times)

• Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of International Patent Application (Psilocybin Alpha)

• Can Psilocybin Assisted Psychotherapy Change Attachment Style? (Psychedelic Science Review)

• Shrooms Movie: The Best (And Worst) Movies to Watch on Shrooms (DoubleBlind)

MDMA

• The Effects of MDMA on Emotional Processing (Truffle Report)

DMT

• Pharmadrug Initiates DMT Research Activities via Collaboration with the University of Michigan for Foundational DMT Research Study (Psilocybin Alpha)

5-MeO-DMT

• Former porn star Nacho Vidal to stand trial for death by toad venom (Euro Weekly News)

Ketamine

• First ketamine-assisted psychotherapy Bristol clinic opens (BBC)

• 'How ketamine helped me kick my alcohol addiction' (The Telegraph)

• Having Sex on Ketamine: Getting Physical on a Dissociative (Reality Sandwich)

• On Ketamine and Memories (Truffle Report)

• Ketamine: A Legal, yet Overlooked Psychedelic (Sapiensoup Blog)

PCP

• Rochester mayor lied to public about Daniel Prude case, report finds (New York Post)

Miscellaneous

• D.C. Psychedelics Decriminalization Initiative Officially Takes Effect (Marijuana Moment)

• Sounding the Alarm on Compass’s Interference with Oregon’s Psilocybin Therapy Program (Dr. Bronner)

• Psychedelic drug users tend to have better overall physical health than non-users, study finds (PsyPost)

• Rhode Island Senators File Drug Decriminalization Bill (Marijuana Moment)

• Psychedelic Capitalism and Other Myths: Is the Joke On Us? (Psychedelics Today)

• Capitalism Goes Rogue with Patent Claims on Psychedelics (Chacruna)

• Australian government backs psychedelic drug clinical trials to treat mental illness (The Guardian)

• Why Oneness is Not Incompatible with Identity Politics (Chacruna)

• The Bread That Made an Entire Island Hallucinate (VICE)

• Psychedelic therapy could 'reset' depressed brain (BBC)

• Do Psychedelics Alter the Menstrual Cycle? (DoubleBlind)

• Psychotic- vs. Psychedelic-Induced Hallucinations: A Closer Look (Psychedelic Science Review)

• ‘The ketamine blew my mind’: can psychedelics cure addiction and depression? (The Guardian)

• Fish and Trips: Psychoactive Denizens of the Deep (Truffle Report)

• Why Microdosing is the Lightsaber of Modern-Day Jedis (The Third Wave)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 9.11.20

Cannabis

• Medical Marijuana Measure Removed From Nebraska’s November Ballot By State Supreme Court (Marijuana Moment)

• Marijuana Is Making Its Mark on Ballots in Red States (The Daily Beast)

• Pakistan Legalizes Industrial and Medical Cannabis Aiming to Expand Global Market (MERRY JANE)

• Maine Finally Approves First Marijuana Business Licenses Weeks Before Legal Sales Launch (Marijuana Moment)

• Give cannabis to elderly people with chronic pain, doctors say (The Telegraph)

• Virginia: Marijuana-Related Bills Advance During Special Legislative Session (NORML)

• USDA Reopens Public Comment Period On Hemp Rules Following Intense Industry Pushback (Marijuana Moment)

• Key Congressional Committee Advances Legislation to Facilitate Clinical Research Studies Using State-Authorized Marijuana Products (NORML)

• Twitter Partners With Feds On Campaign Flagging ‘Marijuana’ Searches While Giving ‘Alcohol’ A Pass (Marijuana Moment)

• Hong Kong Just Opened Its First CBD Café Despite Country's Notoriously Harsh Weed Laws (MERRY JANE)

• Greenstop launches its cannabis vending machine in California dispensaries (TechCrunch)

• Global Drug Body Recommends 20 Ways to Improve the Cannabis Industry (VICE)

• Marijuana Possession Arrests Plummet In Texas After Hemp Legalization, New State Data Shows (Marijuana Moment)

• This is how cannabis effectively eases inflammation (Chicago Tribune)

• I used to be on the police drug squad. Here's why I'm voting against legalising cannabis (Stuff.co.nz)

LSD

• LSD Tolerance Could Develop Faster than You Expect (DoubleBlind)

• Acid Tab Feeling Lot Of Pressure To Present Tech CEO With Game-Changing Ideas For Disrupting Telecom Industry (The Onion)

Magic Mushrooms

• Havn Life Sciences Granted Section 56 Exemption to Begin Scientific Work With Psilocybin (Psilocybin Alpha)

• Bett Williams Walks Between Worlds (Lucid News)

MDMA

• MDMA-Assisted Psychotherapy for PTSD Trials Progressing Through Phase 3 (Psychiatry and Behavioral Health Learning Network)

Nitrous Oxide

• One in four drug users at festivals now get high on laughing gas - TD (Independent.ie)

Ketamine

• Esketamine spray for treating depression 'not cost-effective' (BBC)

• Colorado Society of Anesthesiologists ask CDPHE to suspend 'excited delirium' ketamine waiver (9news.com)

Miscellaneous

• Will Australia be the First Country to Reap the Benefits of Psychedelic Medicines? Rescheduling Proposal Submitted to TGA (Psilocybin Alpha)

• Depression and suicidal ideation reduced after psychedelic usage (Big Think)

• Psychedelic experiences share many features with those described by mystics and religious practitioners (PsyPost)

• Biden Pledges To Force People Who Use Drugs To Enroll In Mandatory Treatment Programs (Marijuana Moment)

• Coronavirus Conspiracy Theories in Psychedelia (Psymposia)

• Psychedelics Company Havn Life Announces Commencement of Public Trading on the CSE (Psilocybin Alpha)

• AWAKN Life Sciences Launches Clinical Research Division with Prof. David Nutt & Dr. Ben Sessa Identifying Suitable Studies Across Europe & North America (Yahoo! Finance)

• How Mescaline Helped Me to Better Understand Schopenhauer’s Philosophy (Psychedelic Frontier)

• Quipazine: A Long-Standing Enigma in Psychedelic Research (Psychedelic Science Review)

• Scientists Use Psychedelics to Discover an Anti-Inflammatory Pharmacophore (Psychedelic Science Review)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.